MRC1 and familial pancreatic carcinoma: I-BET-762 treatment of BMDMs stimulated with conditioned media from pancreatic cancer cells reduced the expression of HO-1 and tumor-promoting markers, such as CCL2, CD206 and arginase 1 (Supplementary Figure S1).